| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
B Activation1
* Immunobiology Program, Department of Medicine, University of Vermont College of Medicine, Burlington, VT 05405;
Center for Biological Resources and Informatics, Tokyo Institute of Technology, Yokohama, Japan; and
Institute of Biochemistry, University of Lausanne, Biomedical Research Center, Epalinges, Switzerland
Cellular FLIP long form (c-FLIPL) was originally identified as an inhibitor of Fas (CD95/Apo-1). Subsequently, additional functions of c-FLIPL were identified through its association with receptor-interacting protein (RIP)1 and TNFR-associated factor 2 to activate NF-
B, as well as by its association with and activation of caspase-8. T cells from c-FLIPL-transgenic (Tg) mice manifest hyperproliferation upon activation, although it was not clear which of the various functions of c-FLIPL was involved. We have further explored the effect of c-FLIPL on CD8+ effector T cell function and its mechanism of action. c-FLIPL-Tg CD8+ T cells have increased proliferation and IL-2 responsiveness to cognate Ags as well as to low-affinity Ag variants, due to increased CD25 expression. They also have a T cytotoxic 2 cytokine phenotype. c-FLIPL-Tg CD8+ T cells manifest greater caspase activity and NF-B activity upon activation. Both augmented proliferation and CD25 expression are blocked by caspase inhibition. c-FLIPL itself is a substrate of the caspase activity in effector T cells, being cleaved to a p43FLIP form. p43FLIP more efficiently recruits RIP1 than full-length c-FLIPL to activate NF-B. c-FLIPL and RIP1 also coimmunoprecipitate with active caspase-8 in effector CD8+ T cells. Thus, one mechanism by which c-FLIPL influences effector T cell function is through its activation of caspase-8, which in turn cleaves c-FLIPL to allow RIP1 recruitment and NF-B activation. This provides a partial explanation of why caspase activity is required to initiate proliferation of resting T cells.
This article has been cited by other articles:
|
|
 |
|
  M. J. Morgan, Y.-S. Kim, and Z.-g. Liu Membrane-Bound Fas Ligand Requires RIP1 for Efficient Activation of Caspase-8 within the Death-Inducing Signaling Complex J. Immunol., September 1, 2009; 183(5): 3278 - 3284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Yu, P. D. Jeffrey, and Y. Shi Mechanism of procaspase-8 activation by c-FLIPL PNAS, May 19, 2009; 106(20): 8169 - 8174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C.R. Emtage, A. S.Y. Lo, E. M. Gomes, D. L. Liu, R. M. Gonzalo-Daganzo, and R. P. Junghans Second-Generation Anti-Carcinoembryonic Antigen Designer T Cells Resist Activation-Induced Cell Death, Proliferate on Tumor Contact, Secrete Cytokines, and Exhibit Superior Antitumor Activity In vivo: A Preclinical Evaluation Clin. Cancer Res., December 15, 2008; 14(24): 8112 - 8122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. L. Ch'en, D. R. Beisner, A. Degterev, C. Lynch, J. Yuan, A. Hoffmann, and S. M. Hedrick Antigen-mediated T cell expansion regulated by parallel pathways of death PNAS, November 11, 2008; 105(45): 17463 - 17468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Zhang, K. Hopkins, and Y.-W. He c-FLIP Protects Mature T Lymphocytes from TCR-Mediated Killing J. Immunol., October 15, 2008; 181(8): 5368 - 5373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Zhang, K. Hopkins, and Y.-W. He The Long Isoform of Cellular FLIP Is Essential for T Lymphocyte Proliferation through an NF-{kappa}B-Independent Pathway J. Immunol., April 15, 2008; 180(8): 5506 - 5511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Truscott, J.-B. Denault, B. Goulet, L. Leduy, G. S. Salvesen, and A. Nepveu Carboxyl-terminal Proteolytic Processing of CUX1 by a Caspase Enables Transcriptional Activation in Proliferating Cells J. Biol. Chem., October 12, 2007; 282(41): 30216 - 30226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Misra, J. Q. Russell, A. Koenig, J. A. Hinshaw-Makepeace, R. Wen, D. Wang, H. Huo, D. R. Littman, U. Ferch, J. Ruland, et al. Caspase-8 and c-FLIPL Associate in Lipid Rafts with NF-{kappa}B Adaptors during T Cell Activation J. Biol. Chem., July 6, 2007; 282(27): 19365 - 19374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Charo and P. F. Robbins Contrasting effects of FLIPL overexpression in human T cells on activation-induced cell death and cytokine production J. Leukoc. Biol., May 1, 2007; 81(5): 1297 - 1302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Meinander, T. S. Soderstrom, A. Kaunisto, M. Poukkula, L. Sistonen, and J. E. Eriksson Fever-Like Hyperthermia Controls T Lymphocyte Persistence by Inducing Degradation of Cellular FLIPshort J. Immunol., March 15, 2007; 178(6): 3944 - 3953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rebe, S. Cathelin, S. Launay, R. Filomenko, L. Prevotat, C. L'Ollivier, E. Gyan, O. Micheau, S. Grant, A. Dubart-Kupperschmitt, et al. Caspase-8 prevents sustained activation of NF-{kappa}B in monocytes undergoing macrophagic differentiation Blood, February 15, 2007; 109(4): 1442 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Rautajoki, E. M. Marttila, T. A. Nyman, and R. Lahesmaa Interleukin-4 Inhibits Caspase-3 by Regulating Several Proteins in the Fas Pathway during Initial Stages of Human T Helper 2 Cell Differentiation Mol. Cell. Proteomics, February 1, 2007; 6(2): 238 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Hyer, T. Samuel, and J. C. Reed The FLIP-Side of Fas Signaling Clin. Cancer Res., October 15, 2006; 12(20): 5929 - 5931. [Full Text] [PDF]
|
|
|
|
|
|
H.-G. Zhang, C. Liu, K. Su, S. Yu, L. Zhang, S. Zhang, J. Wang, X. Cao, W. Grizzle, and R. P. Kimberly A Membrane Form of TNF-{alpha} Presented by Exosomes Delays T Cell Activation-Induced Cell Death. J. Immunol., June 15, 2006; 176(12): 7385 - 7393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Golks, D. Brenner, P. H. Krammer, and I. N. Lavrik The c-FLIP-NH2 terminus (p22-FLIP) induces NF-{kappa}B activation J. Exp. Med., May 15, 2006; 203(5): 1295 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lamkanfi, W. Declercq, T. Vanden Berghe, and P. Vandenabeele Caspases leave the beaten track: caspase-mediated activation of NF-{kappa}B J. Cell Biol., April 24, 2006; 173(2): 165 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Wu, R. S. Misra, J. Q. Russell, R. A. Flavell, M. Rincon, and R. C. Budd Proteolytic Regulation of Nuclear Factor of Activated T (NFAT) c2 Cells and NFAT Activity by Caspase-3 J. Biol. Chem., April 21, 2006; 281(16): 10682 - 10690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Chanvorachote, U. Nimmannit, L. Wang, C. Stehlik, B. Lu, N. Azad, and Y. Rojanasakul Nitric Oxide Negatively Regulates Fas CD95-induced Apoptosis through Inhibition of Ubiquitin-Proteasome-mediated Degradation of FLICE Inhibitory Protein J. Biol. Chem., December 23, 2005; 280(51): 42044 - 42050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Arechiga, B. D. Bell, J. C. Solomon, I. H. Chu, C. L. Dubois, B. E. Hall, T. C. George, D. M. Coder, and C. M. Walsh Cutting Edge: FADD Is Not Required for Antigen Receptor-Mediated NF-{kappa}B Activation J. Immunol., December 15, 2005; 175(12): 7800 - 7804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Beisner, I. L. Ch'en, R. V. Kolla, A. Hoffmann, and S. M. Hedrick Cutting Edge: Innate Immunity Conferred by B Cells Is Regulated by Caspase-8 J. Immunol., September 15, 2005; 175(6): 3469 - 3473. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
